PRE-FEASIBILITY REPORT

of

Intermediates & Bulk Drugs manufacturing unit

By

M/s. Vadivarhe Speciality Chemicals Ltd.

At

Gut No. – 204, Nashik – Mumbai highway, A/p – Vadivarhe,

Tal. – Igatpuri, Dist. – Nashik – 422 403

Maharashtra

1

INDEX

Sr. no. Description Page no.

1.0 Executive Summery 2

2.0 Introduction of project 3

2.1 Project proponent 3

2.2 Brief description of nature of the project 3

2.3 Need for the project & its important to the country and or

region

3

2.4 Demand supply Gap 4

2.5 Employment generation (Direct & Indirect) due to the project 5

3.0 Project description 5

3.1 Products & product capacity 7

3.2 Raw material requirement 10

3.3 Manufacturing process 10

3.4 Resource-utilize & recycling 11

3.4.1 Water Requirement 11

3.4.2 Power requirement 12

3.4.3 Fuel requirement 12

3.5 Quantity of waste to be generated 12

3.5.1 Waste water generation & utilization 12

3.5.2 Solid waste generation & disposal 13

3.6 Schematic representations of the feasibility drawing which give

information of EIA purpose

13

4.0 Site Analysis 13

4.1 Land Form, Land use and Land ownership. 13

4.2 Existing Infrastructure 14

4.3 Soil classification 14

4.4 Climatic data from secondary sources 14

4.5 Social Infrastructure available 14

5.0 Planning Brief 14

6.0 Proposed Infrastructure 14

6.1 Project Area 14

6.2 Residential Area 14

6.3 Green Belt 14

6.4 Social Infrastructure 15

6.5 Occupation health 15

7.0 Rehabilitation and Resettlement (R & R) Plan 15

8.0 Project Schedule & Cost Estimates 15

9.0 Analysis of proposal (Final Recommendations) 16

2

1.0 Executive Summery

M/s. Vadivarhe Speciality Chemicals Ltd. Proposed is for Bulk Drugs & Drugs Intermediates

manufacturing project at Gut No. – 204, Nashik – Mumbai highway, A/p – Vadivarhe, Tal. –

Igatpuri, Dist. – Nashik – 422 403 (Maharashtra).

Table: Summary of Proposed Plant

Sr.No. Parameter Description

1 Name And Address M/s. Vadivarhe Specialty Chemicals Ltd. (VSCL)

Gut No. – 204, Nashik – Mumbai highway, A/p –

Vadivarhe, Tal. – Igatpuri, Dist. – Nashik – 422 403

Maharashtra

2 Category of Project as per

EIA Notification

5(f) “B”

3 Proposed Project Cost Rs. 22 crore

4 Area of the project Total Area - 12500 Sq. M.

Built-up area: 3908.74 Sq. M

Green Belt area: 4125 Sq. M

Utility block: 363 Sq. M.

Boiler House: 74.12 Sq. M.

5 Latitude & Longitude Latitude: 19°50' 52.79"N

Longitude: 73°40'44.56"E

6 Product Bulk Drugs & Drugs Intermediates

7 Existing Production Capacity

with Consent to Operate

13.3 MT/M

Proposed Production Capacity

With Consent to Establish

9.321 MT/M (8.089+1.142)

Additional new product

Capacity

1152.03MT/M

Total Production 1174.651 MT/M

8 Capacity of Boiler 850 kg

9 Total water Requirement 95.4 m3/day

10 Waste Water Generation 44.41 m3/day

11 Total Power Requirement 150 KVA

12 Total Fuel Requirement 1) LDO - 500 liter/day 2) HSD – 50 Liter/day

13 Manpower Direct employment:

1. Permanent Staff : 70 nos

2. Permanent Workers : 16 nos

Indirect Employment:

1. Contract Workers – 100 nos

3

2.0 Introduction/Brief Project Description

The objective of this pre feasibility study is to provide information for the Bulk Drugs and

Intermediates manufacturing unit by M/s. Vadivarhe Speciality Chemicals Ltd. Gut No. – 204,

Nashik – Mumbai highway, A/p – Vadivarhe, Tal. – Igatpuri, Dist. – Nashik – 422 403

(Maharashtra).

M/s Vadivarhe Speciality Chemicals Ltd. is a reputed name in the Bulk Drugs & Drugs

Intermediates manufacturing. It is a limited organization engaged in manufacturing Bulk Drugs &

Drugs Intermediates manufacturing products.

The M/s. Vadivarhe Speciality Chemicals Ltd. has been incorporated with main object to

manufacture Bulk Drugs & Intermediates which have a good export potential. The ever-

increasing demand for the products in India & Abroad has prompted the promoters to undertake

manufacturing of some selected Bulk Drugs & Intermediates. As per the provision of “EIA

Notification No.S.O.1533 (E)” dated 14.09.2006 as amended on December 01, 2009, the project

comes under “Category A”

2.1 Project Proponent

M/s. Vadivarhe Speciality Chemical Ltd. is incorporated in the year 2007 to manufacture Bulk

Drug & Intermediates Mr. Vasant Jagtap is the managing Director of this Company Having

experience in Bulk Drug manufacturing & R&D for more than 20 years.

2.2 Brief Description of Nature of The Project

The proposed project is to manufacture synthetic organic chemicals (Bulk Drug) of

1174.651MT/M capacity. The pharmaceutical industry includes the manufacture, extraction,

processing, purification & packing of chemical materials to be used as medicines .Pharmaceutical

manufacturing is divided into two major stages the production of active ingredient or

drug(Primary processing or manufacturing & Secondary processing) the conversion of the active

drugs into products suitable for administration.

2.3 Need for The Project & It’s Importance To The Country & Or Region

Mumbai & Surrounding area has emerged as major drug manufacture city with a presence in

global market. Pharma industry in the state contribute more than one third to the country total

production.

Most of the companies have set up their R&D facilities in the state, thus making the state the

pharmaceutical capital of the country .

Mumbai & Surrounding has developed as major production center for bulk drugs due to the

location if the many major pharmaceutical industries such as Lupin ltd, Matrix Labs, Cipla,

Ranbaxy etc. besides a large no. of medium & small industries manufacturing Bulk Drugs of all

kinds.

The Indian Pharmaceutical Industry today is in the front rank of India’s science based industry

with wide ranging capabilities in the complex field of drug manufacture & technology .

4

Bulk drugs have become a part of our life for sustaining many of our day-to day

activities, preventing & controlling diseases. Bulk drug manufacturing sector in

India is well established & has recorded a steady growth in the overall Indian

industrial scenario. The bulk drug & allied industries have been amongst the fatest

growing segments of the Indian Industry.

India’s pharmaceutical industry is the third largest in the world in terms of volume.

Its rank is 14th

in terms of value. India is also one of the top five active

pharmaceutical ingredients (API) producers (with a share of about 6.5%)

The ever-increasing demand for bulk drug & intermediated in India & abroad as

well as changing market condition for manufacture & sale of products has prompted

the promoters to go for manufacturing of Bulk Drug & Intermediates as well as

chemicals.

2.4 Demands-Supply Gap

As per IMS Retail Drug Monitor, sales through pharmacies in thirteen leading markets for the

year to August 2003 are $ 298.7 Billion. According to the IMS World Review, in 2004 global

audited sales of pharmaceuticals rose 8% (at constant dollar rate) to reach US $ 400.6 Billion.

IMS world Review tracks actual sales of approximately 90% of all prescription drugs & certain

over-the-counter (OTC) products in more than 70 countries. Using proprietor data projection

methodologies to estimate total global pharmaceutical sales, which grew to US $ 430.3 Billion in

2005. Despite economic challenges in the world’s leading markets & a lower than normal number

of new products introduction, the global pharmaceutical industry experienced good growth in

2005.

During 2005-06, the state produced bulk drug & formulations worth US $ 2.5 billion. The exports

from the state stood at US $ 1.0 billion in 2004-05 registering an annual growth of more than 20%

the sector accounts for about 20% of the total exports from state

Imports Vs Indigenous Production

The products including third generation antibiotics are high in demand in the export market. Also

their demand is increasing in the domestic market. Production of these drugs domestically reduces

the need to import these in future along with significant scope for export in these products.

Domestic/ Export Markets

In the initial phase the products shall comprise of mainly intermediates which shall be supplied to

domestic API firms. Subsequently when the blocks for APIs will be erected, the APIs will be

supplied to both domestic as well as export market

5

2.5 Employment Generation (Direct & Indirect) Due To The Project

The activities under industry would produce improvement in the socio-economic status of people

in the study area in terms of local labor employment & contract basis jobs. The proposed activity

might provide employment opportunities to the local populace, especially in business & other

services like transportation activity.

It is expected to direct or indirect employ about 50-60 people of various skills will be required

during construction as well as operation phase.

The details of employment shown in below table-

Particulars N0. Of

Employees Functional

Key managerial staff &

Administration

30 Finance, Marketing , Production,

Quality Control, R&D, Logistic Office

work etc

Skilled & semiskilled 60 Production process , Maintenance

stores, Safety & un Skilled workers.

Total 90

3.0 Project Description

M/s. Vadivarhe Speciality Chemicals Ltd. manufacturing unit at Gut No.204, Nashik-Mumbai

highway, A/P-Vadivarhe, Tal-Igatpuri, Dist-Nashik-422403 (Maharashtra) Location map is

shown at Figure.

Latitude: 19°50' 52.79"N

Longitude: 73°40'44.56"E

There are no archaeological, historical sites located near project site. Therefore, the project site

does not offer any negative impact on the local area. But rather have a positive impact on socio

economic conditions of the habitants around it.

The plant is well connected with National Highway No.3 (NH3) at 0.5 KM from Site & Railway

line at Igatpuri Railway station at 20.87 km & Nashik Railway station at 20.25 km. The total of

about 12500 Sq. Mt. of land is acquired for this project.

6

Figure: Location Map

Project Site

7

3.1 The List Product & Production capacity is given below.

Sr. No. A) List of Existing Product with Consent to Operate

Annual Production

Quantity MT/Month

1 Trimethyl Ortho Proplonate (MOP) 0.25

2 Tributly Ortho Proplonate (BOP) 0.1

3 Trimetthyl Ortho Valerate (MOV) 0.2

4 Tributyl Ortho Valerate (BOV) 0.25

5 Trimethyl Ortho Butyrate (MOBu) 0.05

6 Trimethyl Ortho Benzoate (MOB) 0.05

7 4- Aminomorpholine (4AM) 0.4

8 Ethyl-N-dodecanoyl-L-Arginate Hydrochloride 0.5

9 Ethyl Atropate (EA) 0.5

10 3-Aminophthalhydrazide (3APH) 0.2

11 3-Aminophthalhydrazide Sodium Salt 0.05

12 1-Bromo 4 Tert Butyl Benzene 0.5

13 N-N Dimethyl Formamide Dimethyl Acetal (DMFDMA) 0.2

14 Tert-Butoxy bis (dimethyl amino) methane 0.2

15 Brji (wax) 3.0

16 Hydol (wax) 3.0

17 Stereoamido propyl dimethyl amine (wax) (SAPDMA) 3.0

18 Sodium Thioglycolate (NaTG) 0.1

19 Calcium Thioglycolate (CaTG) 0.1

20 Miscellaneous Chemicals in R&D lab 0.2

By-Product

1 Hydrobromic acid (30%solution) 0.19

2 Ammonium Chloride 0.25

B) List of Product with Consent to Establish for Expansion -1

21 Adapalene 0.005

22 Atorvastatin 0.008

23 Brimonidine 0.005

24 Bromfenac 0.002

25 Deslortadine 0.025

26 Escitalopram Oxalate 0.1

27 Febuxostat 0.04

28 Gabapentin 0.1

29 Glimepride 0.12

30 Montelukast Na 0.1

31 Moxifloxacin 0.7

32 Nitazpxanide 0.5

33 Olopatadine 0.002

34 Olanzapine 0.1

35 Olmesartan 0.025

8

36 Prasugrel 0.03

37 Risperidone 0.025

38 Rosuvastatin calcium 0.1

39 Strontium 0.15

40 Tazarotene 0.002

41 Telmisartan 0.3

42 Trospium 0.05

43 Ezetimibe 0.04

44 Citalopram Hydrobromide 0.05

45 Phenylephrine Hydrochloride 5

46 Niacinamide 0.01

47 Fructopyranose Sulfamate/ Topiramate 0.5

C) List of Product with Consent to Establish for Expansion-2

48 Losartan Potassium 0.1

49 Irbesartan 0.05

50 Valsartan 0.02

51 Telmisartan 0.02

52 Olmesartan Medoxomil 0.02

53 Carvedilol 0.1

54 Sotalol Hydrochloride 0.025

55 Fluticasone Propionate 0.001

56 Salmeterol xinafoate 0.002

57 Formeterol Fumarate 0.002

58 Montelucast Sodium 0.02

59 Pranlucast Hydrate 0.02

60 Methdilazine Hydrochloride 0.05

61 Lamotrizine 0.05

62 Pregabalin 0.1

63 Brimonidine Tartarate 0.002

64 Dorzolamide Hydrochloride 0.02

65 Betmethasone Dipropionate 0.02

66 Betmethasone Valerate 0.02

67 Ambroxol Hydrochloride 0.5

D. List of New Product-

68 Quinoline-6 carboxylic acid 1

69 Di methyl malonic acid (New Addition ) 0.1

70 4-chloro-3-nitroanisole 1

71 Sodium hippurate hydrate 1

72 4-Morpholinoaniline 0.1

73 N-Benzylglycine ethyl ester 0.5

74 6-Methoxyquinoline 0.1

75 1-Bromo2-Methyl propane 0.5

76 Indole-3-methanol(Indole-3-cabinol) 0.1

77 Indole-3-carboxylic acid 0.1

9

78 Indole-5-carboxylic acid 0.1

79 3-(Dimethylaminomethyl)Indole (Gramine) 0.01

80 Trimethyl Orthoacetate 0.5

81 Cheamide 5

82 L-Cystine disodium Salt 0.1

83 Methdilazine hydrochloride 0.5

84 Indole-3-carboxaldehyde (Indole-3-aldehyde) 0.1

85 3-Cynoindole 0.1

86

Tert-Butoxy-bis(dimethyl amino) mehane (Brederk”s

reagent)

2.4

87 Propionyl chloride 0.5

88 3-Aminophthalhydrazide sodium salt 0.6

89 Phenyl phosphate disodium salt 0.1

90 Aloe Vera Juice (Stabilised) 1000

91 Lecithin powder 0.1

92 Ammonium thioglycolate (Solution) 1

93 5-Bromo,5-Nitro,1:3Dioxane 0.5

94 Phenylepherin Hydrochloride (PPH) 0.5

95 Heck Coupled Product 0.1

96 Chloro Atavaquinone 0.1

97 Immidazolyl acetic acid 0.1

98 Montelukast sodium 0.6

99 Moxifloxacin hydrochloride 24

100 Topiramate 3

101 Risperidone 0.6

102 Olopatadine hydrochloride 0.005

103 Escitalopram oxalate 1.2

104 Brimonidine tartrate 0.018

105 Strontium ranelate 1.2

106 Desloratidine 2.4

107 Olmesartan Medoxomil 0.1

108 Nitazoxanide 0.5

109 Atorvastatin calcium 24

110 Bromfenac sodium 0.018

111 Febuxostat 3

112 Prasugrel hydrochloride 0.2

113 Alcaftadine 0.004

114 Cinacalcet hydrochloride 0.1

115 Dapoxetine hydrochloride 0.3

116 Desloratidine 24

117 Dimethyl Fumarate 0.12

118 Losartan Potassium 18

119 Nitazoxanide 3

120 Pitvastatin Calcium 0.06

10

121 Flavoxate hydrochloride 0.06

122 Flovoxamine Maleate 0.06

123 Timolol maleate 0.06

124 Ketoprofen 5

125 Clopidogrel Bisulfate 5

126 Tetrabenazine 0.2

127 Agomelatine 0.2

128 Rupatadine Fumarate 1.2

129 Lymecycline 2.4

130 Dexketoprofen trometamol 12

131 Trospium chloride 0.1

132 Almotriptan maleate 0.005

133 Dronedarone hydrochloride 1

134 Lurasidone hydrochloride 0.01

135 Milrinone 0.002

136 Pramipexole dihydrochloride 0.006

137 Pregabalin 1.2

138 Teriflunamide 0.06

139 Roflumilast 0.002

140 Solefenacin 0.003

141 Tolperisone hydrochloride 0.1

Total Production Capacity- 1174.524MT/M

3.2 Raw material requirement

All the raw materials required for manufacturing of above products will be sourced from local

market- List is attached

3.3 Manufacturing Process: The manufacturing process of bulk drug consist of chemical

synthesis extending to stages of processing involving different type of chemical reaction. The

generalized flow chart for bulk drug manufacturing is shown in Flow chart

Generalized flow chart for Bulk Drug Manufacturing-

11

3.4 Resource – Utilize & Recycling

3.4.1-Water Requirement

Water requirement of the project for domestic & Industrial activity during operation phase is 94.4

m3/day The water requirement sourced from Bore well The detailed water requirement shown in

below Table

Table water Requirement details

Purpose Water Consumption Losses Effluent

Exist

Water

Cons.

(m3/d)

Prop.

Water

Cons.

(m3/d)

Total

Water

Cons.

(m3/d)

Loss

Exist.

Water

(m3/d)

Prop.

Water

(m3/d)

Total

Loss

(m3/d)

Effluent

Exist.

(m3/d)

Effluent

Prop.

(m3/d)

Total

Effluent

after

Expansion

(m3/d)

Industrial

processing

6.41 49.0 55.41 0.20 15.0 15.20 6.21 34.0 40.21

Industrial

cooling and

Boiler

18.0 5.0 23 18.0 5.0 23.0 Nil Nil Nil

Domestic 2.0 3.0 5 0.2 0.6 0.8 1.8 2.4 4.2

Gardening 11.99 Nil 11.99 11.99 Nil 11.99 Nil Nil Nil

Total 38.4 57 95.4 30.39 20.6 50.99 8.01 36.4 44.41

12

The total water requirement after expansion will be 95.4 M3/day. The water requirement is

fulfilled from Own Bore well and tanker.

3.3.2 Power Requirement

The power requirement after expansion will be around 150 Kw. The source of power is MSEB

and DG Sets. The DG Set having 250 KVA capacities for power failure.

3.4.3 Fuel Requirement

Total LDO Requirement is around 500 lit/day and HSD 50 Lit/day

3.5 Quantity of wastes to be generated

3.5.1 Waste Water Generation and utilization

Total effluent generated in the project is 44.41 KLD. The treated water will be reused for plant

operations.

Waste Water Treatment

Effluent generated from the project will be treated through effluent treatment plant. Existing ETP

having Capacity 50 CMD. ETP flow chart attached

ETP Flow Chart

Air Blower

Process

Effluent

Domestic

effluent

Oil & grease trap

Eqn/Neutn tank -2 no

Anaerobic digester

SAFF

Bioreactor Sec clarifier tank

Filter press

Sand filter & Carbon filter

Treated Water Effluent pump

Treated Water Tank

Clar water tank

Primary Parallel plate settler tank

Filter Cake

Filtrate

Title : Flow Diagram of E.T.P.

Client : Vadivharhe Specialty Chemicals Ltd,Nasik

By Universal Associates

13

3.5.2 Solid waste generation & disposal

The types of Hazardous and non Hazardous wastes generated from the project, method of disposal

is shown in below table

The Solid waste will be classified into hazardous waste and other waste which is being handled

under the agency of Pollution Control Board. The industry entered into an agreement with

Common hazardous waste treatment and disposal facility (CHWTSDF) where the waste is

characterized and scientifically disposed off in a secured Landfill after Stabilization to prevent

any sought of impact on environment

Table: Hazardous Waste Quantity

Sr. No. Cat. Name of

Hazardous Waste

Existing

Qty

Proposed Total Disposal

1 20.3 Distillation

Residues

2.5 Kg/day Nil 2.5

Kg/Day

CHWTSDF

2 28.1 Waste Residue Nil CHWTSDF

3 28.5 Spent Solvent Nil CHWTSDF

4 34.3 ETP Sludge 0.8

MT/Year

6.2

MT/Month

7

MT/Month

CHWTSDF

5 35.1 Filter Cloth 5

Kg/Month

Nil 5 Month CHWTSDF

3.6 Schematic representations of the feasibility drawing which give information of EIA

purpose.

The applicability of the S.O. 1533 for the proposed project was explored by considering different

possibilities & provision made in the said Notification. Considering the products & project

location of the proposed project it is noiticed that the proposed project falls under category 5 (F)

“A” of the Schedule – I of EIA Notification SO 1533.

4.0 Site Analysis

M/s. Vadivarhe Speciality Chemicals Ltd. is located at Gut No. – 204, Nashik – Mumbai

highway, A/p – Vadivarhe, Tal. – Igatpuri, Dist. – Nashik – 422 403 (Maharashtra).

The nearest habitation from the site is Vadivarhe (Village) at a distance of 1.2 KM.

The nearest railway station is Igatpuri at a distance of 20.87 KMs from the site.

The nearest airport is Nashik Air port at a distance of 40 KMs

The Nearest road ways National (NH – 3)

4.1 Land Form, Land use and Land ownership.

The proposed land for setting bulk drug unit in Notified Industrial Estate of 12500.00 SQ. M. The

land is acquired by M/s. Vadivarhe Speciality Chemicals Ltd. for establishing their

Manufacturing Facility

14

4.2 Existing Infrastructure.

There is well established existing Infrastructure at proposed Site because it is located in

Vadivarhe Village

4.3 Soil classification

The district is mainly covered by three types of soils Viz. red sandy soil (Dubbas and Chalkas)

Red earth (with loamy sub-soils and Chalkas) and black cotton soils. Red andy soils and red earth

are permeable and well drained.

4.4 Climatic data from secondary sources

Temperature Maximum: 35.9 °C

Minimum: 12.5 °C

Normal annual rainfall 814 mm

4.5 Social Infrastructure available

The social infrastructure facilities are available near to proposed site.

5.0 Planning Brief

Proposed plant activities will be started after getting statutory clearance form related authorities.

The project will be completed within two years.

Further proposed project activities will take care of all the rules and regulation of statutory

authority and provide the control measure and devices to achieve the standard norms

6.0 Proposed Infrastructure

6.1 Project Area

Basic infrastructure to be developed along with civil construction and installation of required

plant and machineries.

6.2 Residential Area

No residential area is involved in the proposed project. The employees are accommodated in

nearby Residential areas

6.3 Green Belt

The unit has already developed green belt area @ 3500 sq. m within and on the surrounding of the

existing premises and will also increase the green belt @ 625 sq. m (Total after expansion 4125

15

sq. m) which will not only improve the soil conditioning but will also prevent soil erosion and the

landscape & give slight beneficial impact on the land usage.

6.4 Social Infrastructure

The Vadivarhe Specialty Chemicals Ltd. project has generated a fair amount of direct and indirect

employment in the study region. The local economy has received a boost due to employee

spending and services generated by Vadivarhe Specialty Chemicals Ltd. Migration into the

existing area or displacement of existing population is insignificant. Housing, transport, water,

power supply, medical, educational and other civic amenities are not adversely affected nor

appear to get affected in future.

6.5 Occupation health

Various precautions have been taken by the unit to reduce health hazardous and medical check-up

is also carried out regularly to avoid occupational hazard.

Drinking water supply for the employees is provided by the project proponent and the

standard of the drinking water is as per WHO guidelines.

Proper sanitary facilities are made available by the project proponent so that employees do

not suffer from any health ailments.

Training includes information on accident prevention, proper control and maintenance of

equipment and safe material handling practices.

MSDS of the chemical used are made available at the place of use.

Storage and process areas are posted with “No Smoking” signs. Smoking is prohibited

throughout the factory. All management staff, Executives on their rounds to factory

ensures the compliance.

Pre-employment medical check-up at the time of employment.

The unit has appointed the medical officer cum industrial hygienist for the regular medical

examination and treatment of the employee.

Certificate of fitness of employ is maintained.

Equipment required for personal safety like water jet blankets, gloves, helmets, safety

belts, first aid boxes etc. are provided.

7.0 Rehabilitation and Resettlement (R & R) Plan

Rehabilitation & Resettlement (R&R) plan is not applicable to proposed project it is proposed is

located at existing premise

8.0 Project Schedule & Cost Estimates

Proposed project activities will be started after getting statutory clearance form related authorities.

The project will be completed within two years

16

Sr. No. Particulars Amount Rs in lakhs

1 Land 44,72,000.00

2 Factory Building 6,41,81,068.00

3 Plant & Machinery &

Equipments

9,33,11,969.00

4 Furniture & Fixture 22,05,789.00

5 Other Movable/ Immovable

Fixed assets

4,58,49,088.00

Total 21,00,19,914.00

Cost of environmental protection measures (Rs. Lakhs)

No. ITEM Capital Cost

(Rs, Lacs)

Recurring Cost per

annum (Lacs)

1 Air Pollution Control 20 5

2 Water Pollution Control 75 10

3 Noise Pollution Control 5 1

4 Environment Monitoring and Management 10 2

5 Rain Water Harvesting 15 1

6 Occupational Health 10 2

7 Green Belt 5 2

8 Safety management. 5 2

9 Laboratory and chemicals 10 3

10 Operation & Maintenance of ETP - 12

Total 170 35

9.0 Analysis of proposal (Final Recommendations)

Proposed expansion activity will provide benefits to the local people in terms of financial and

social welfare.

Local people will get direct financial benefit by way of employment.

Local people will get some contracts of supply and services to get indirect income.

Company will contribute in improving education and health facilities in nearby area.